Ruedi Wealth Management’s AbbVie ABBV Stock Holding History

Ruedi Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-446	Closed	-$93.5K	–	57
2025 Q1	$93.5K	Buy	446 +1	+0.2%	+$194	0.03%	71
2024 Q4	$79.1K	Buy	445 +2	+0.5%	+$368	0.03%	75
2024 Q3	$87.5K	Sell	443 -51	-10%	-$9.52K	0.03%	71
2024 Q2	$84.7K	Buy	494 +54	+12%	+$8.95K	0.03%	70
2024 Q1	$80.2K	Buy	440 +1	+0.2%	+$172	0.03%	68
2023 Q4	$68K	Hold	439	–	–	0.03%	70
2023 Q3	$65.4K	Hold	439	–	–	0.04%	64
2023 Q2	$59.1K	Hold	439	–	–	0.03%	68
2023 Q1	$70K	Hold	439	–	–	0.05%	65
2022 Q4	$70.9K	Buy	+439	New	+$67.3K	0.05%	62

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ruedi Wealth Management's ABBV Position: Q2 2025 in Review

Ruedi Wealth Management sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 446 shares — an estimated $93.5K sold.

Ruedi Wealth Management first reported a position in ABBV in Q4 2022 and held it in 10 quarters. The position peaked at $93.5K in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Ruedi Wealth Management reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
Ruedi Wealth Management sold 446 AbbVie shares in Q2 2025, an estimated $93.5K.
Ruedi Wealth Management first reported a position in AbbVie in Q4 2022 and held it in 10 quarters.
Ruedi Wealth Management's AbbVie position peaked at $93.5K in Q1 2025.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Ruedi Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.